Abstract:Ulcerative colitis (UC) is a chronic non-specific inflammatory bowel disease, which usually manifests as abdominal pain, diarrhea and hematochezia. The disease often recurs and is difficult to cure. At present, the pathogenesis is not clear, but it is believed that the disease is caused by a complex interaction among immunity, heredity, environment and intestinal microflora disorders. MicroRNA (miRNA) is endogenous single-stranded non-coding RNA of 17–25 nucleotides (nts). They target the 3'Untranslated Region of a target gene and inhibit or degrade the target gene according to the extent of complementary bases. As important gene expression regulators, miRNAs are involved in regulating the expression of most human genes, and play an important role in the pathogenesis of many autoimmune diseases including UC. Studies in recent years have illustrated that abnormal expression of miRNA occurs very early in disease pathogenesis. Moreover, this abnormal expression is highly related to disease activity of UC and colitis-associated cancer, and involves virtually all key UC-related mechanisms, such as immunity and intestinal microbiota dysregulation. Recently, it was discovered that miRNA is highly stable outside the cell in the form of microvesicles, exosomes or apoptotic vesicles, which raises the possibility that miRNA may serve as a novel diagnostic marker for UC. In this review, we summarize the biosynthetic pathway and the function of miRNA, and summarize the usefulness of miRNA for diagnosis, monitoring and prognosis of UC. Then, we described four types of miRNAs involved in regulating the mechanisms of UC occurrence and development: 1) miRNAs are involved in regulating immune cells; 2) affect the intestinal epithelial cells barrier; 3) regulate the homeostasis between gut microbiota and the host; and 4) participate in the formation of tumor in UC. Altogether, we aim to emphasize the close relationship between miRNA and UC as well as to propose that the field has value for developing potential biomarkers as well as therapeutic targets for UC.

Micrornas As Therapeutic Targets in Intestinal Diseases

MicroRNAs in Colorectal Cancer As Markers and Targets: Recent Advances.

MicroRNAs in colorectal carcinoma--from pathogenesis to therapy

miRNA-Based Potential Biomarkers and New Molecular Insights in Ulcerative Colitis

MicroRNAs (miRNAs): Novel potential therapeutic targets in colorectal cancer

MicroRNAs Regulate Intestinal Immunity and Gut Microbiota for Gastrointestinal Health: A Comprehensive Review

MicroRNAs: Novel Immunotherapeutic Targets in Colorectal Carcinoma.

The Role of microRNAs in Development of Colitis-Associated Colorectal Cancer

MiRNAs: a new target for Chinese medicine to repair the intestinal barrier in the treatment of ulcerative colitis

Updated immunomodulatory roles of gut flora and microRNAs in inflammatory bowel diseases

MicroRNAs in inflammatory bowel disease: What do we know and what can we expect?

MicroRNAs Are Key Molecules Involved in the Gene Regulation Network of Colorectal Cancer

Function of Micrornas in Development of Immune System and in Regulation of Immune Response

MicroRNA signatures in the pathogenesis and therapy of inflammatory bowel disease

MicroRNA expression in inflammatory bowel disease-associated colorectal cancer

MicroRNAs as potential therapeutic targets for pancreatic cancer

Functional Implications and Clinical Potential of MicroRNAs in Irritable Bowel Syndrome: A Concise Review

MicroRNAs in the Intestine: Role in Renewal, Homeostasis, and Inflammation

Fecal microRNAs as Innovative Biomarkers of Intestinal Diseases and Effective Players in Host-Microbiome Interactions

Investigation of key miRNAs and their target genes in inflammatory bowel diseases and colitis-associated colorectal cancers using miRNA proifling and bioinformatic tools

MicroRNAs: Multifaceted Regulators of Colorectal Cancer Metastasis and Clinical Applications